(9926.HK) today announced that results from a Phase II clinical study evaluating its first-in-class PD-1/VEGF bispecific ...

A groundbreaking, first-of-its-kind advancement marks a new era in reverse shoulder arthroplasty, culminating in eight years ...

MNTN reported third-quarter 2026 adjusted earnings of $0.10 per share, missing the $0.25 consensus, and cut its full-year ...

Veracyte stock fell more than 50% after the Company reported on November 4, 2026 that Decipher Prostate volume fell short of ...

Other investors say October financial results could lessen the blow of the market rout. AI Companies Scramble to Navigate a World Hostile to Data Centers With winning candidates promising moratoriums ...

Approval extends existing U.K. indication for Joenja to eligible children aged 4 to 11 who weigh at least 27 kg; Joenja is expected to become available to patients covered by the ...

Vallourec, a world leader in premium tubular solutions, announces today the signing of a new €750 million multicurrency revolving credit facility (RCF). The new facility replaces both the existing ...

Logic-gated Switch-DARPin design enables potent, selective cytotoxicity against cells co-expressing tumor-associated antigens (TAAs) previously considered undruggable for T cell engagers Favorable ...

Oil futures rebounded from the previous session's heavy losses while the market maintained hopes for the U.S. and Iran to come to an agreement following the midterm elections. U.S. Natural Gas Futures ...

Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, announced that the New Drug Application (NDA) ...

NEWPORT, R.I., Nov. 5, 2026 /PRNewswire/ -- Pangaea Logistics Solutions Ltd. ("Pangaea" or the "Company") (Nasdaq: PANL), a ...

"The Arc is a significant investment in Rice's future and in Houston's continued growth as a center for innovation," said ...